SEC Comment Letter 0000000000-24-007843 to Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Date: July 10, 2024 · CIK: 0001106838 · Accession: 0000000000-24-007843
AI Filing Summary & Sentiment
File numbers found in text: 333-280705
Letter
July 10, 2024 Pankaj Mohan, Ph.D. CEO and Chairman Sonnet BioTherapeutics Holdings, Inc. 100 Overlook Center, Suite 102 Princeton, New Jersey 08540 Re:Sonnet BioTherapeutics Holdings, Inc. Registration Statement on Form S-3 Filed July 5, 2024 File No. 333-280705 Dear Pankaj Mohan Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Steven M. Skolnick, Esq.
Show Raw Text
July 10, 2024
Pankaj Mohan, Ph.D.
CEO and Chairman
Sonnet BioTherapeutics Holdings, Inc.
100 Overlook Center, Suite 102
Princeton, New Jersey 08540
Re:Sonnet BioTherapeutics Holdings, Inc.
Registration Statement on Form S-3
Filed July 5, 2024
File No. 333-280705
Dear Pankaj Mohan Ph.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Steven M. Skolnick, Esq.